JOHN B HENNEMAN III Insider Trading $APRE Aprea Therapeutics, Inc.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for JOHN B HENNEMAN III.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of JOHN B HENNEMAN III. JOHN B HENNEMAN III is Director in Anika Therapeutics, Inc. ($ANIK) and Chief Administrative Officer in NEWLINK GENETICS CORP ($NLNK) and EVP, Chief Financial Officer in NEWLINK GENETICS CORP ($NLNK) and Director in Accretive Health, Inc. ($AH) and Director in SeaSpine Holdings Corp ($SPNE) and in Aprea Therapeutics, Inc. ($APRE).

JOHN B HENNEMAN III in Aprea Therapeutics, Inc.

Trading Symbol: APRE
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of JOHN B HENNEMAN III:
Holdings: 5,000 shares
Latest Transaction: Jul 01 2020

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of JOHN B HENNEMAN III in Aprea Therapeutics, Inc.

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, ANIK, APRE, NLNK, AH, SPNE

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Jul 01 2020APREAprea Therapeutics ...HENNEMAN JOHN B IIIOption ExerciseA38.785,600217,1685,600
Oct 07 2019APREAprea Therapeutics ...HENNEMAN JOHN B IIIOption ExerciseA15.0018,407276,10518,407
Oct 07 2019APREAprea Therapeutics ...HENNEMAN JOHN B IIIOption ExerciseA15.0018,407276,10518,407
Oct 07 2019APREAprea Therapeutics ...HENNEMAN JOHN B IIIBuyP15.005,00075,0005,0000 to 5 K
Oct 07 2019APREAprea Therapeutics ...HENNEMAN JOHN B IIIBuyP15.005,00075,0005,0000 to 5 K

Page:   1